Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
Case Comprehensive Cancer Center
Stanford University
OHSU Knight Cancer Institute
Vanderbilt-Ingram Cancer Center